An independent panel of independent advisers for the Centers for Disease Control and Prevention backed Pfizer's respiratory syncytial virus, or RSV, vaccine for pregnant women to confer immunity to newborns on Friday.
The panel recommended that pregnant women between 32 and 36 weeks gestation during cold and flu season take the RSV vaccine that was recently approved by the Food and Drug Administration for adults over the age of 60.In July, the FDA also approved an RSV vaccine for infants and toddlers over eight months old, which was recommended by CDC Director Mandy Cohen in August.
RSV causes mild symptoms in most people with healthy immune systems, but elderly adults and children under the age of 3 are at greater risk.Over 2 million children under the age of 5 are treated outside of the hospital for RSV annually, and up to 80,000 children less than 5 are hospitalized. Between 100 and 300 child deaths yearly are attributable to RSV.
Cohen will need to issue the final approval of the panel's recommendation before the vaccine can be administered to mothers.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US CDC panel weighs use of Pfizer's maternal RSV vaccine to protect infantsA panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday will vote on the use of Pfizer's respiratory syncytial virus (RSV) vaccine in pregnant women, likely paving the way for it to become the country's first maternal shot for protecting babies from the virus.
Read more »
Pfizer maternal RSV vaccine recommended by CDC advisorsA Centers for Disease Control and Prevention advisory committee on Friday recommended pregnant people get Pfizer Inc.’s maternal vaccine to protect babies...
Read more »
CDC advisors recommend Pfizer maternal RSV vaccine to protect infantsCDC Director Mandy Cohen still needs to sign off on that recommendation before mothers can receive Pfizer’s shot to protect their infants from RSV.
Read more »
Pfizer maternal RSV vaccine recommended by CDC advisersNew shot aims to protect babies from a leading cause of hospitalization.
Read more »
CDC committee recommends RSV vaccine given to pregnant people to protect their babiesThe vaccine is the first of its kind to be approved. It can shield infants from respiratory syncytial virus during their first 6 months.
Read more »
Another tool to fight RSV may be coming for parentsThe CDC’s vaccine advisory committee will meet today to deliberate who should receive Pfizer’s maternal RSV vaccine.
Read more »